Tyrosine Phosphorylation in Alzheimer's Disease

阿尔茨海默病中的酪氨酸磷酸化

• 批准号: 7038075
• 负责人: Gloria Lee
• 金额: $ 26.88万
• 依托单位: UNIVERSITY OF IOWA
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-05-01 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7038075
• 关键词: Alzheimer' s disease; biomarker; cell death; cell line; disease /disorder model; enzyme activity; gene mutation; genetically modified animals; immunocytochemistry; laboratory mouse; molecular pathology; phosphorylation; protein isoforms; protein localization; protein protein interaction; protein structure function; protein tyrosine kinase; surface plasmon resonance; tau proteins

DESCRIPTION (provided by applicant): Abnormal tau is a common feature of several age related neurodegenerative diseases. In Alzheimer's disease tau forms neurofibrillary tangles, that along with amyloid plaques, comprise the major neuropath- ological features of the disease. In several frontotemporal dementias, tau is mutated. Also, in other fronto- temporal dementias as well as in progressive supranuclear palsy and corticobasal degeneration, only specific isoforms of tau are featured in the neuropathology. The mechanisms by which neuronal cells die in these diseases is unknown. Our research focuses on a new interaction for tau that identifies tau as a signal transduction protein. As a binding partner for the SH3 domain of src family tyrosine kinases, we have found that tau is tyrosine phosphorylated and is capable of up-regulating kinase activity. Our preliminary data also shows that disease related structural modifications in tau increase its affinity for the SH3 domain of fyn. Therefore, we hypothesize that the interaction between tau and fyn is a critical event in the neurodegenera- tive process. The specific aims of this proposal will 1) use animal models for frontotemporal dementia and Alzheimer's disease to investigate the temporal and spatial appearance of tyrosine phosphorylated tau relative to other neuropathological features; 2) further our knowledge of the tyrosine kinases that act on tau; 3) extend our analysis of the interaction between disease related isoforms of tau and the SH3 domain of fyn; 4) elucidate the structural basis for the differential SH3 binding ability of four repeat versus three repeat tau; and 5) investigate the functional consequences of up-regulated src family tyrosine kinase activity in neuronal cells, focusing on cell cycle characteristics and susceptibility to apoptosis. Our working model is that phosphorylated 4R tau and/or tau FTDP-17 missense mutants have an increased ability to up-regulate fyn and/or src activity. In neurons, this increase in tyrosine kinase activity would result in the activation of signal transduction pathways, such as those involved in cell division or apoptosis, that eventually lead to cell death. This model is consistent with a gain of toxic function for tau and the autosomal dominant aspect of FTDP-17 mutations. The identification of the fyn-tau interaction as a critical event in the neurodegenerative process would suggest new candidate targets for therapeutic interventions.

描述（由申请人提供）：异常tau蛋白是几种年龄相关神经退行性疾病的共同特征。在阿尔茨海默病中，tau形成神经元缠结，其沿着淀粉样蛋白斑块，构成该疾病的主要神经病理学特征。在几种额颞叶痴呆中，tau蛋白发生了突变。此外，在其他额颞痴呆以及进行性核上性麻痹和皮质基底节变性中，只有特定的tau亚型在神经病理学中具有特征。神经元细胞在这些疾病中死亡的机制尚不清楚。我们的研究重点是tau的一种新的相互作用，将tau确定为信号转导蛋白。作为src家族酪氨酸激酶的SH 3结构域的结合伴侣，我们发现tau是酪氨酸磷酸化的并且能够上调激酶活性。我们的初步数据还表明，疾病相关的tau结构修饰增加了其对fyn的SH 3结构域的亲和力。因此，我们假设tau蛋白和fyn蛋白之间的相互作用是神经退行性变过程中的一个关键事件。该建议的具体目的是1）使用额颞叶痴呆和阿尔茨海默病的动物模型来研究酪氨酸磷酸化tau相对于其他神经病理学特征的时间和空间表现; 2）进一步我们对作用于tau的酪氨酸激酶的知识; 3）扩展我们对疾病相关的tau亚型和fyn的SH 3结构域之间的相互作用的分析; 4）阐明四个重复相对于三个重复tau的差异SH 3结合能力的结构基础;和5）研究神经元细胞中上调的src家族酪氨酸激酶活性的功能后果，集中于细胞周期特征和对凋亡的敏感性。我们的工作模型是磷酸化的4 R tau和/或tau FTDP-17错义突变体具有增加的上调fyn和/或src活性的能力。在神经元中，酪氨酸激酶活性的这种增加将导致信号转导途径的激活，例如参与细胞分裂或凋亡的那些，最终导致细胞死亡。该模型与tau的毒性功能获得和FTDP-17突变的常染色体显性方面一致。将fyn-tau相互作用鉴定为神经退行性过程中的关键事件将为治疗干预提供新的候选靶点。